Cancer

An Interview with Peter Nakada of RMS

Peter Nakada is a Managing Director, capital markets at Risk Management Solutions (RMS).  We had a chance to speak to Peter about...

S. Jay Olshansky on Why the Message is All About Extending Health

S. Jay Olshansky is a Professor in the School of Public Health at the University of Illinois at Chicago and Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine. Much of Dr. Olshanky's research has focused on the upper limits to human longevity and the health and public policy implications associated with aging.  We had an opportunity to connect with Jay at the recent SOA Living to 100 Symposium.

AD: As an expert in...

Companies: 

Potential Longevity Benefits Seen from Cellular Senescence Experiment

Wired magazine recently reported on longevity -related research that involves the successful application of technology to cellular senescence . Cellular senescence is a term that describes the aging and overall breakdown of cells. The problem with the aging cells is that they do not die and disappear from the body. Scientists believe that the old, broken-down cells stick around and contribute to the degeneration of healthy cells in a body and ultimately to age-related diseases such as cancer...
Key Phrases: 

RMS Model Provides a New Perspective on Longevity Risk

Risk Management Solutions (RMS) is well known as a leader in the area of catastrophe modeling and analytics.  The company provides its services to a broad range of insurers, reinsurers, consultants and capital markets participants who are active in the property and casualty insurance industry.

More recently, the company has developed resources that focus on life and health risks.  Though initially focused on...

Doctor Brandon Colby on Predictive Medicine, the Power of Prevention and Planning for a Long Retirement

Brandon Colby, MD, is a world leader in the field of...

Companies: 

Pages